Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 22.22 is 22% below its 3-year average of 28.62, around the middle of its 3-year range (0.00–57.95).
As of the fiscal period ended Tuesday, June 30, 2026. 9.74% below its 12-month average of 24.62.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 22.22.
CURRENT RATIO
22.22
CURRENT RATIO AVG TTM
24.62
CURRENT RATIO AVG 3Y
27.62
CURRENT RATIO AVG 5Y
N/A
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-9.74%
CURRENT VS 3Y AVG
-19.54%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+492.52%
vs the sector median at left
Market Cap
$5.47B
Current Ratio
1.81
TTM Avg
1.62
3Y Avg
1.66
5Y Avg
1.66
Market Cap
$5.82B
Current Ratio
4.35
TTM Avg
3.47
3Y Avg
3.74
5Y Avg
5.38
Market Cap
$5.87B
Current Ratio
3.90
TTM Avg
3.54
3Y Avg
4.15
5Y Avg
5.24
Market Cap
$5.92B
Current Ratio
31.18
TTM Avg
15.58
3Y Avg
12.00
5Y Avg
10.69
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CG Oncology Inc. (CGON) | $5.59B | 22.22 | 24.62 | 27.62 | N/A |
| RadNet, Inc. (RDNT)vs › | $5.51B | 1.48 | 1.94 | 1.50 | 1.26 |
| MiniMed Group, Inc. Common Stock (MMED)vs › | $5.47B | 1.81 | 1.62 | 1.66 | 1.66 |
| Iovance Biotherapeutics, Inc. (IOVA)vs › | $5.82B | 4.35 | 3.47 | 3.74 | 5.38 |
| Kodiak Sciences Inc. (KOD)vs › | $5.81B | 2.49 | 5.72 | 6.91 | 11.65 |
| Kiniksa Pharmaceuticals International, plc (KNSA)vs › | $5.87B | 3.90 | 3.54 | 4.15 | 5.24 |
| GRAIL Inc. (GRAL)vs › | $5.90B | 10.95 | 11.32 | 6.44 | 5.89 |
| PTC Therapeutics, Inc. (PTCT)vs › | $5.29B | 3.39 | 2.35 | 2.11 | 2.46 |
| Ligand Pharmaceuticals Incorporated (LGND)vs › | $5.92B | 31.18 | 15.58 | 12.00 | 10.69 |
| CRISPR Therapeutics AG (CRSP)vs › | $5.22B | 17.85 | 17.70 | 17.06 | 17.77 |
Current Ratio
22.22
Quick Ratio
22.20
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 22.22 |
| 2026-03-31 | 31.30 |
| 2025-12-31 | 24.63 |
| 2025-09-30 | 22.79 |
| 2025-06-30 | 22.15 |
| 2025-03-31 | 30.97 |
| 2024-12-31 | 35.30 |
| 2024-09-30 | 35.32 |
| 2024-06-30 | 47.57 |
| 2024-03-31 | 57.95 |
| 2023-12-31 | 13.62 |
| 2023-09-30 | 17.92 |
| 2023-06-30 | 57.95 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 9.54 |
